Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis

Koumaki, Dimitra and Koumaki, Vasiliki and Bertsias, George and Lagoudaki, Eleni and Bertsias, George (2019) Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis. European Journal of Case Reports in Internal Medicine, 7 (1). ISSN 2284-2594

[img]
Preview
Text
document (2).pdf - Published Version

Download (748kB) | Preview
Official URL: https://www.ejcrim.com/index.php/EJCRIM/article/vi...

Abstract

Objectives: Baricitinib is an orally active Janus kinase (JAK) inhibitor used in the treatment of moderate to severe rheumatoid arthritis (RA). Materials and methods: Here, we report the case of a 56-year-old Caucasian male diagnosed with RA who developed palmoplantar pustulosis (PPP) while being treated with baricitinib. Results: The patient’s PPP resolved after discontinuation of baricitinib and recurred when this was restarted. Based on causality assessment, it was considered a drug-induced PPP. Conclusion: To the authors’ knowledge, this is the first case of baricitinib-induced PPP.

Item Type: Article
Uncontrolled Keywords: Palmoplantar pustulosis, baricitinib, rheumatoid arthritis, cutaneous side effects
Subjects: 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale)
Depositing User: Chiara D'Arpa
Date Deposited: 19 Nov 2020 09:49
Last Modified: 19 Nov 2020 09:49
URI: http://eprints.bice.rm.cnr.it/id/eprint/19770

Actions (login required)

View Item View Item